Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2018
Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNSJerusha Naidoo, Lisa M Stanek, Kousaku Ohno, et al.
Science Translational Medicine|August 23, 2019
Adeno-associated viral vector serotype 9-based gene therapy for Niemann-Pick disease type ALluis Samaranch, Azucena Pérez-Cañamás, Beatriz Soto-Huelin, et al.
Neurology|October 15, 2021
Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 TrialChadwick W Christine, R Mark Richardson, Amber D Van Laar, et al.
Neuro-Oncology|May 22, 2010
Canine spontaneous glioma: a translational model system for convection-enhanced deliveryPeter J Dickinson, Richard A LeCouteur, Robert J Higgins, et al.
Molecular Therapy. Methods & Clinical Development|January 23, 2019
Kinetics and MR-Based Monitoring of AAV9 Vector Delivery into Cerebrospinal Fluid of Nonhuman PrimatesKousaku Ohno, Lluis Samaranch, Piotr Hadaczek, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 8, 2024
Persistent GDNF Expression 45 Months after Putaminal Infusion of AAV2-GDNF in a Patient with Parkinson's DiseaseJohn D Heiss, Abhik Ray-Chaudhury, David E Kleiner, et al.
Journal of Parkinson'S Disease|February 17, 2025
Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshopRoger A Barker, Mart Saarma, Clive N Svendsen, et al.
Nature Medicine|August 14, 2023
GDNF gene therapy for alcohol use disorder in male non-human primatesMatthew M Ford, Brianna E George, Victor S Van Laar, et al.
Pageof 12